Search research articles
Contact Us
Filters
Showing results (331-340 of 350) with videos related to
Page
of 35
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
November 2, 2005
Immunogenicity, including vitiligo, and feasibility of vaccination with autologous GM-CSF-transduced tumor cells in metastatic melanoma patients
Rosalie M Luiten, Esther W M Kueter, Wolter Mooi, et al.
Annals of Surgical Oncology
|
May 18, 2024
The Effect of Neoadjuvant Systemic Therapy on Surgical Outcomes After Lymph Node Dissections for Stage III Melanoma; An Australian Cohort
Lisanne P Zijlker, Henry Chen, Andrew J Spillane, et al.
The Lancet. Oncology
|
June 8, 2019
Neoadjuvant dabrafenib combined with trametinib for resectable, stage IIIB-C, BRAF<sup>V600</sup> mutation-positive melanoma (NeoCombi): a single-arm, open-label, single-centre, phase 2 trial
Georgina V Long, Robyn P M Saw, Serigne Lo, et al.
Journal of Translational Medicine
|
September 5, 2022
Higher polygenic risk for melanoma is associated with improved survival in a high ultraviolet radiation setting
Mathias Seviiri, Richard A Scolyer, D Timothy Bishop, et al.
European Journal of Cancer (Oxford, England : 1990)
|
June 14, 2021
Re-defining the role of surgery in the management of patients with oligometastatic stage IV melanoma in the era of effective systemic therapies
Sydney Ch'ng, Semra Uyulmaz, Matteo S Carlino, et al.
Oncoimmunology
|
April 11, 2018
Anti-Melanoma immunity and local regression of cutaneous metastases in melanoma patients treated with monobenzone and imiquimod; a phase 2 a trial
Hansje-Eva Teulings, Esther P M Tjin, Karina J Willemsen, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
February 27, 2021
Technologic (R)Evolution Leads to Detection of More Sentinel Nodes in Patients with Melanoma in the Head and Neck Region
Danique M S Berger, Nynke S van den Berg, Vincent van der Noort, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
April 27, 2011
Prognosis in patients with sentinel node-positive melanoma is accurately defined by the combined Rotterdam tumor load and Dewar topography criteria
Augustinus P T van der Ploeg, Alexander C J van Akkooi, Piotr Rutkowski, et al.
Annals of Surgical Oncology
|
November 15, 2023
Role of Concurrent Ultrasound Surveillance of Sentinel Node-Positive Node Fields in Melanoma Patients Having Routine Cross-Sectional Imaging
Caroline A Gjorup, Rachel Woodford, Isabel Li, et al.
Annals of Surgical Oncology
|
February 23, 2017
The Impact of Smoking on Sentinel Node Metastasis of Primary Cutaneous Melanoma
Maris S Jones, Peter C Jones, Stacey L Stern, et al.
Page
of 35
Search research articles
Search
Showing results (331-340 of 350) with videos related to
Sort By:
Page
of 35
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
November 2, 2005
Immunogenicity, including vitiligo, and feasibility of vaccination with autologous GM-CSF-transduced tumor cells in metastatic melanoma patients
Rosalie M Luiten, Esther W M Kueter, Wolter Mooi, et al.
Annals of Surgical Oncology
|
May 18, 2024
The Effect of Neoadjuvant Systemic Therapy on Surgical Outcomes After Lymph Node Dissections for Stage III Melanoma; An Australian Cohort
Lisanne P Zijlker, Henry Chen, Andrew J Spillane, et al.
The Lancet. Oncology
|
June 8, 2019
Neoadjuvant dabrafenib combined with trametinib for resectable, stage IIIB-C, BRAF<sup>V600</sup> mutation-positive melanoma (NeoCombi): a single-arm, open-label, single-centre, phase 2 trial
Georgina V Long, Robyn P M Saw, Serigne Lo, et al.
Journal of Translational Medicine
|
September 5, 2022
Higher polygenic risk for melanoma is associated with improved survival in a high ultraviolet radiation setting
Mathias Seviiri, Richard A Scolyer, D Timothy Bishop, et al.
European Journal of Cancer (Oxford, England : 1990)
|
June 14, 2021
Re-defining the role of surgery in the management of patients with oligometastatic stage IV melanoma in the era of effective systemic therapies
Sydney Ch'ng, Semra Uyulmaz, Matteo S Carlino, et al.
Oncoimmunology
|
April 11, 2018
Anti-Melanoma immunity and local regression of cutaneous metastases in melanoma patients treated with monobenzone and imiquimod; a phase 2 a trial
Hansje-Eva Teulings, Esther P M Tjin, Karina J Willemsen, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
February 27, 2021
Technologic (R)Evolution Leads to Detection of More Sentinel Nodes in Patients with Melanoma in the Head and Neck Region
Danique M S Berger, Nynke S van den Berg, Vincent van der Noort, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
April 27, 2011
Prognosis in patients with sentinel node-positive melanoma is accurately defined by the combined Rotterdam tumor load and Dewar topography criteria
Augustinus P T van der Ploeg, Alexander C J van Akkooi, Piotr Rutkowski, et al.
Annals of Surgical Oncology
|
November 15, 2023
Role of Concurrent Ultrasound Surveillance of Sentinel Node-Positive Node Fields in Melanoma Patients Having Routine Cross-Sectional Imaging
Caroline A Gjorup, Rachel Woodford, Isabel Li, et al.
Annals of Surgical Oncology
|
February 23, 2017
The Impact of Smoking on Sentinel Node Metastasis of Primary Cutaneous Melanoma
Maris S Jones, Peter C Jones, Stacey L Stern, et al.
Page
of 35